Navigation Links
Daniel J. Berry, MD, Named Academy Second Vice President
Date:2/27/2009

LAS VEGAS, Feb. 27 /PRNewswire-USNewswire/ -- Orthopaedic surgeon Daniel J. Berry, MD, was elected to the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org/) Board of Directors at the 2009 Annual Meeting. He will serve the Academy as Second-Vice President.

"Being an orthopaedic surgeon gives me the opportunity to have a dramatic positive effect on patients' lives," explained Dr. Berry. "I am humbled and honored to serve in this leadership role. I also look forward to dedicating myself to the opportunities and challenges the orthopaedic landscape faces."

A graduate of Dartmouth College and Harvard Medical School, Dr. Berry completed orthopaedic surgery residencies at Harvard, Brigham and Women's Hospital and Massachusetts General Hospital. He completed his fellowship at Mayo Clinic in Rochester, Minnesota. Currently, he serves as professor of orthopaedics, College of Medicine at Mayo Clinic and chair in the Department of Orthopaedic Surgery at Mayo Clinic.

Active in the AAOS since 1998, Dr. Berry has served on numerous committees and task forces, including the Academy's American Joint Replacement Registry Oversight Board and the CME Courses Committee. He most recently served as president of the American Association of Hip and Knee Surgeons (AAHKS) and held previous leadership roles for the American Board of Orthopaedic Surgery (ABOS), the Hip Society and the Mid America Orthopaedic Association.

"By participating in orthopaedic organizations and societies, I have had the opportunity to work with, and learn from, a remarkably talented group of individuals who have become some of my life-long friends," said Dr. Berry.

As an orthopaedic researcher, Dr. Berry has received numerous honors and accolades including awards for clinical research from the Hip Society, the Knee Society, the AAHKS, and the Orthopedic Research and Education Foundation (OREF). He is the author or co-author of over 117 peer-reviewed publications and 62 book chapters. Dr. Berry has made scientific presentations at over 330 regional, national and international meetings.

Dr. Berry's main focus areas for the AAOS include:

  • Continuing to enhance orthopaedic patient care through innovation and patient advocacy.
  • Maintaining and expanding relationships with each of the orthopaedic specialty societies, sister U.S. and international orthopaedic organizations and societies.
  • Advancing quality orthopaedic care and orthopaedic education for each of our members.

"Dan represents all the qualities that the AAOS is looking for in the leadership of the Academy," stated John Callaghan, MD, incoming first vice president of the AAOS. "There is no one I know who represents a leader more than Dan."

When not in the operating room or seeing patients, Dr. Berry enjoys the outdoors and traveling. He is an avid fly fisherman and downhill and cross country skier. He spends any free time with his wife, Camilla, and two children, Charlotte and John.

More about Daniel J. Berry, MD

(http://mayoresearch.mayo.edu/mayo/research/staff/berry_dj.cfm)

About AAOS

(http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=40&releasenum=735)

    For more information, contact:

    Catherine Dolf
    (O) 847-384-4034
    (C) 847-894-9112
    dolf@aaos.org

    Lauren Pearson
    (O) 847-384-4031
    (C) 224-387-8610
    lpearson@aaos.org



'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
2. Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards
3. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
4. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
5. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
6. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
7. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
8. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
9. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
10. Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
11. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... New York, NY (PRWEB) , ... June 19, 2017 , ... ... and this year, it’s going to be a humdinger. A warm winter and wet ... devour summer wedding guests. “No one wants to be swatting away pesky mosquitoes when ...
(Date:6/19/2017)... ... June 19, 2017 , ... ... to foster the international exchange of actionable insights to improve health globally through ... mission to make clinical trial management faster, easier, and less painful. Attendees can ...
(Date:6/19/2017)... ... June 19, 2017 , ... Intalere, ... its annual Emerging Technology Show at its Elevate 2017 meeting in Orlando, Fla. ... those proposing new, enhanced products and services to Intalere members. , “Intalere is ...
(Date:6/19/2017)... Lake Orion, Michigan (PRWEB) , ... June 19, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse, but they also require a comprehensive approach that can help for preservation ...
(Date:6/19/2017)... , ... June 19, 2017 , ... ... a health care company that offers health insurance plans to families and individuals ... be the sole provider of breast pumps for Molina members effective July 2017. ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... Pa. , June 1, 2017 Nutriceutical ... and Veterinarian Recommended Solutions (VRS), and KD Pharma Group ... in Nutriceutical Holdings by KD Pharma Group. KD Pharma ... with the option to acquire the entire company. ... in KD. They are committed to growing the NH ...
(Date:5/30/2017)... May 30, 2017 Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced ... overview at three upcoming scientific and investor conferences ... Micro Invitational: ... Date:                     Wednesday, ...
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
Breaking Medicine Technology: